Literature DB >> 21808278

Diabetes: Lowering serum uric acid levels to prevent kidney failure.

Alessandro Doria, Andrzej S Krolewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21808278     DOI： 10.1038/nrneph.2011.107

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.

Authors:  Yan Miao; Stefan A Ottenbros; Goos D Laverman; Barry M Brenner; Mark E Cooper; Hans-Henrik Parving; Diederick E Grobbee; Shahnaz Shahinfar; Dick de Zeeuw; Hiddo J Lambers Heerspink
Journal:  Hypertension       Date:  2011-05-31       Impact factor: 10.190

2.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Authors:  Marian Goicoechea; Soledad García de Vinuesa; Ursula Verdalles; Caridad Ruiz-Caro; Jara Ampuero; Abraham Rincón; David Arroyo; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

3.  Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.

Authors:  Yui-Pong Siu; Kay-Tai Leung; Matthew Ka-Hang Tong; Tze-Hoi Kwan
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

4.  Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Authors:  Michael A Becker; H Ralph Schumacher; Robert L Wortmann; Patricia A MacDonald; Denise Eustace; William A Palo; Janet Streit; Nancy Joseph-Ridge
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

5.  Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Authors:  Elizabeth T Rosolowsky; Jan Skupien; Adam M Smiles; Monika Niewczas; Bijan Roshan; Robert Stanton; John H Eckfeldt; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

Review 6.  Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

Authors:  Richard J Johnson; Mark S Segal; Titte Srinivas; Ahsan Ejaz; Wei Mu; Carlos Roncal; Laura G Sánchez-Lozada; Michael Gersch; Bernardo Rodriguez-Iturbe; Duk-Hee Kang; Jaime Herrera Acosta
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

7.  High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.

Authors:  Linda H Ficociello; Elizabeth T Rosolowsky; Monika A Niewczas; Nicholas J Maselli; Janice M Weinberg; Ann Aschengrau; John H Eckfeldt; Robert C Stanton; Andrzej T Galecki; Alessandro Doria; James H Warram; Andrzej S Krolewski
Journal:  Diabetes Care       Date:  2010-03-23       Impact factor: 17.152

8.  A role for uric acid in the progression of renal disease.

Authors:  Duk-Hee Kang; Takahiko Nakagawa; Lili Feng; Susumu Watanabe; Lin Han; Marilda Mazzali; Luan Truong; Raymond Harris; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

9.  Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.

Authors:  Diana I Jalal; Christopher J Rivard; Richard J Johnson; David M Maahs; Kimberly McFann; Marian Rewers; Janet K Snell-Bergeon
Journal:  Nephrol Dial Transplant       Date:  2010-01-11       Impact factor: 5.992

10.  Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study.

Authors:  Peter Hovind; Peter Rossing; Lise Tarnow; Richard J Johnson; Hans-Henrik Parving
Journal:  Diabetes       Date:  2009-05-01       Impact factor: 9.461
  10 in total
  6 in total

Review 1.  Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism.

Authors:  Weier Qi; Qian Li; Daniel Gordin; George L King
Journal:  J Mol Med (Berl)       Date:  2018-03-24       Impact factor: 4.599

2.  Association of serum uric acid with proteinuria in type 2 diabetic patients.

Authors:  Saeed Behradmanesh; Mohammad Karami Horestani; Azar Baradaran; Hamid Nasri
Journal:  J Res Med Sci       Date:  2013-01       Impact factor: 1.852

3.  Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis.

Authors:  Yili Xu; Jiayu Zhu; Li Gao; Yun Liu; Jie Shen; Chong Shen; Glenn Matfin; Xiaohong Wu
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

4.  Uricosuric targets of tranilast.

Authors:  Asim K Mandal; Adriana Mercado; Andria Foster; Kambiz Zandi-Nejad; David B Mount
Journal:  Pharmacol Res Perspect       Date:  2017-02-06

5.  Elevation of serum uric acid and incidence of type 2 diabetes: A systematic review and meta-analysis.

Authors:  Yi-Li Xu; Kuan-Feng Xu; Jian-Ling Bai; Yun Liu; Rong-Bin Yu; Chun-Lan Liu; Chong Shen; Xiao-Hong Wu
Journal:  Chronic Dis Transl Med       Date:  2016-11-02

6.  Genome-wide association analysis confirms and extends the association of SLC2A9 with serum uric acid levels to Mexican Americans.

Authors:  Venkata Saroja Voruganti; Jack W Kent; Subrata Debnath; Shelley A Cole; Karin Haack; Harald H H Göring; Melanie A Carless; Joanne E Curran; Matthew P Johnson; Laura Almasy; Thomas D Dyer; Jean W Maccluer; Eric K Moses; Hanna E Abboud; Michael C Mahaney; John Blangero; Anthony G Comuzzie
Journal:  Front Genet       Date:  2013-12-16       Impact factor: 4.599
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.